Lymphoid organ dendritic cells: Beyond the Langerhans cells paradigm

Immunology and Cell Biology

Volumn 82, Issue 1, 2004, Pages 91-98

  Wilson, Nicholas S ^a   Villadangos, Jose A ^a,b  

^a Department of Civil and Environmental Engineering   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Antigen presentation; Dendritic cells; Human; Immunity; Lymphoid organs; Major histocompatibility complex; Mouse; T cells; Tolerance

Indexed keywords

CD11B ANTIGEN; CD205 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095; LANGERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; BORRELIA; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; LANGERHANS CELL; LEISHMANIA; LIFESPAN; LYMPHOID ORGAN; NONHUMAN; PLASMODIUM; REVIEW; SPLEEN; SUBCUTANEOUS TISSUE; THYMUS; TRYPANOSOMA; YELLOW FEVER FLAVIVIRUS; YERSINIA;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DENDRITIC CELLS; HUMANS; LANGERHANS CELLS; LYMPHOID TISSUE;

ANIMALIA; BORRELIA; FLAVIVIRUS; TRYPANOSOMA; YELLOW FEVER VIRUS; YERSINIA;

EID: 1642379407     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2004.01216.x     Document Type: Review

References (84)

1. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu. Rev. Immunol. 2003; 21. 139-76.
2. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000; 18: 767-811.
3. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002; 20: 621-67.
4. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 1985; 161: 526-46.
5. Romani N, Koide S, Crowley M et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 1989; 169: 1169-78.
6. Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp Med. 1994; 180: 1849-60.
7. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nature Rev. Immunol. 2002; 2: 116-26.
8. Pure E, Inaba K, Crowley MT et al. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 1990; 172: 1459-69.
9. Shimada S, Caughman SW, Sharrow SO, Stephany D, Katz SI. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen. J. Immunol. 1987; 139: 2551-5.
10. Witmer-Pack MD, Valinsky J, Olivier W, Steinman RM. Quantitation of surface antigens on cultured murine epidermal Langerhans cells: rapid and selective increase in the level of surface MHC products. J. Invest. Dermatol. 1988; 90: 387-94.
11. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991; 9: 271-96.
12. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992; 176: 1693-702.
13. Winzler C, Rovere P, Rescigno M et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 1997; 185: 317-28.
14. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994; 179: 1109-18.
15. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997; 388: 782-7.
16. Pierre P, Turley SJ, Gatti E et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997; 388: 787-92.
17. Lopez JA, Hart DN. Current issues in dendritic cell cancer immunotherapy. Curr. Opin Mol Ther. 2002; 4: 54-63.
18. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr. Opin Immunol. 2003; 15: 138-47.
19. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2002; 2: 151-61.
20. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 1990; 172: 1483-93.
21. Stoitzner P, Holzmann S, McLellan AD et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 2003; 120: 266-74.
22. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 1987; 166: 1654-67.
23. Itano AA, Jenkins MK. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 2003; 4: 733-9.
24. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev. Immunol. 2001; 1: 135-45.
25. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 2001; 193: 51-60.
26. Huang FP, Platt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 2000; 191: 435-44.
27. Matsuno K, Ezaki T, Kudo S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J. Exp. Med. 1996; 183: 1865-78.
28. De Smedt T, Pajak B, Muraille E et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 1996; 184: 1413-24.
29. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 1997; 156: 25-37.
30. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002; 100: 1734-41.
31. Kamath AT, Pooley J, O'Keeffe MA et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000; 165: 6762-70.
32. Ardavin C. Origin, precursors and differentiation of mouse dendritic cells. Nat. Rev. Immunol. 2003; 3: 582-90.
33. Naik S, Vremec D, Wu L, O'Keeffe M, Shortman K. CD8alpha+ mouse spleen dendritic cells do not originate from the CD8alpha-dendritic cell subset. Blood 2003; 102: 601-4.
34. Gretz JE, Anderson AO, Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 1997; 156: 11-24.
35. Bujdoso R, Hopkins J, Dutia BM, Young P, McConnell I. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J. Exp. Med. 1989; 170: 1285-301.
36. Brand CU, Gerber HA, Hunziker T, Schaffner T, Limat A, Brathen LR. Phenotype of Langerhans cells in human afferent skin lymph derived from allergic contact dermatitis. Exp. Dermatol. 1993; 2: 274-9.
37. Howard CJ, Sopp P, Brownlie J, Parsons KR, Kwong LS, Collins RA. Afferent lymph veiled cells stimulate proliferative responses in allogeneic CD4+ and CD8+ T cells but not gamma delta TCR+ T cells. Immunology 1996; 88: 558-64.
38. Lukas M, Stossel H, Hefel L et al. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 1996; 106: 1293-9.
39. Geissmann F, Dieu-Nosjean MC, Dezutter C et al. Accumulation of immature langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 2002; 196: 417-30.
40. Salomon B, Cohen JL, Masurier C, Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 1998; 160: 708-17.
41. Anjuere F, Martin P, Ferrero I et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 1999; 93: 590-8.
42. Ruedl C, Koebel P, Bachmann M, Hess M, Karjalainen K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 2000; 165: 4910-6.
43. Henri S, Vremec D, Kamath A et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 2001; 167: 741-8.
44. Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 1993; 92: 2587-96.
45. Itano AA, McSorley SJ, Reinhardt RL et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003; 19: 47-57.
46. Wilson NS, El-Sukkari D, Belz GT et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003; 102: 2187-94.
47. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000; 164: 2978-86.
48. O'Keeffe M, Hochrein H, Vremec D et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J. Exp. Med. 2002; 196: 1307-19.
49. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001; 98: 3520-6.
50. Nakano H, Yanagita M, Gunn MD. CD11c(+) B220(+) Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001; 194: 1171-8.
51. Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001; 2: 1144-50.
52. Martin P, Del Hoyo GM, Anjuere F et al. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002; 100: 383-90.
53. Hochrein H, O'Keeffe M, Wagner H. Human and mouse plasmacytoid dendritic cells. Hum. Immunol. 2002; 63: 1103-10.
54. Krug A, Veeraswamy R, Pekosz A et al. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 2003; 197: 899-906.
55. Fonteneau JF, Gilliet M, Larsson M et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 2003; 101: 3520-6.
56. Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 2002; 14: 373-9.
57. Vremec D, Zorbas M, Scollay R et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 1992; 176: 47-58.
58. O'Keeffe M, Hochrein H, Vremec D et al. Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors. Blood 2003; 101: 1453-9.
59. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 1997; 159: 565-73.
60. Edwards AD, Diebold SS, Slack EM et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 2003; 33: 827-33.
61. Wilson NS, El-Sukkari D, Villadangos JA. Dendritic cells constitutively present self antigens in their immature state in vivo, and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 2003 (in press).
62. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 2002; 196: 1079-90.
63. Belz GT, Behrens GM, Smith CM et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 2002; 196: 1099-104.
64. Inaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 1998; 188: 2163-73.
65. Allan RS, Smith CM, Belz GT et al. Epidermal viral immunity induced by CDSalpha+ dendritic cells but not by Langerhans cells. Science 2003; 301: 1925-8.
66. Takahashi K, Asagoe K, Zaishun J et al. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. Am. J. Pathol. 1998; 153: 745-55.
67. Schmitt C, Fohrer H, Beaudet S et al. Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo. J. Leukoc Biol. 2000; 68: 836-44.
68. Bendriss-Vermare N, Barthelemy C, Durand I et al. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J. Clin. Invest. 2001; 107: 835-44.
69. Vandenabeele S, Hochrein H, Mavaddat N, Winkel K, Shortman K. Human thymus contains 2 distinct dendritic cell populations. Blood 2001; 97: 1733-41.
70. Summers KL, Hock BD, McKenzie JL, Hart DN. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 2001; 159: 285-95.
71. Mcllroy D, Troadec C, Grassi F et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood 2001; 97: 3470-7.
72. Ruedl C, Koebel P, Karjalainen K. In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J. Immunol. 2001; 166: 7178-82.
73. El-Sukkari D, Wilson NS, Hakansson K et al. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 2003; 171: 5003-11.
74. Randolph GJ. Is maturation required for langerhans cell migration? J. Exp. Med. 2002; 196: 413-6.
75. Luft T, Jefford M, Luetjens P et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 2002; 100: 1362-72.
76. Huh JC, Strickland DH, Jahnsen FL et al. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J. Exp. Med. 2003; 198: 19-30.
77. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 1997; 185: 541-50.
78. Palmer E. Negative selection - clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 2003; 3: 383-91.
79. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003; 21: 685-711.
80. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2001; 2: 1010-7.
81. Schulz O, Edwards AD, Schito M et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000; 13: 453-62.
82. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000; 1: 305-10.
83. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 2002; 196: 1627-38.
84. Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001; 194: 769-79.